@article{46653,
      author = {Fink, Carsten,},
      url = {http://tind.wipo.int/record/46653},
      title = {Calculating Private and Social Returns to COVID-19 Vaccine  Innovation.},
      abstract = {What is the return to COVID-19 vaccine innovation? This  paper seeks to quantify both private and social returns,  using available data on commercialized vaccines and certain  assumptions about the pandemic’s epidemiological path as  well as the economic costs of containment measures. The  calculations reveal high returns to innovation. In the  baseline scenario, the social benefit of vaccine innovation  amounts to 70.5 trillion United States (U.S.) dollars  globally, exceeding its private benefit by a factor of 887.  The calculations bear on the private and public incentives  to invest in vaccine innovation.},
      doi = {https://doi.org/10.34667/tind.46653},
      recid = {46653},
      pages = {19 pages ;},
}